LLY – eli lilly and company (US:NASDAQ)
Stock Stats
News
12/26
04:43 am
lly
Low
Buying This Pharmaceutical Stock Could Make You a Millionaire Retiree [Yahoo! Finance]
12/25
11:48 pm
lly
Low
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly [Yahoo! Finance]
12/25
07:00 pm
lly
Low
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle? [Yahoo! Finance]
12/25
12:08 pm
lly
Low
As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock? [Yahoo! Finance]
12/24
09:13 pm
lly
Low
Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies [Yahoo! Finance]
10/30/2025
06:45 am
LLY
-1.0%
BEAT
8/7/2025
06:45 am
LLY
-1.6%
BEAT
5/1/2025
06:45 am
LLY
-7.9%
MISS
2/6/2025
06:45 am
LLY
4.9%
MISS
12/19
10:07 am
Reiterates
Outperform
Outperform
Sanford C. Bernstein
Low
0.4%
12/18
03:03 pm
Reiterates
Outperform
Outperform
Leerink Partners
Low
-0.5%
12/18
12:03 pm
Reiterates
Neutral
Neutral
UBS Group AG
Low
-1.0%
12/16
05:31 am
Upgrades
NEUTRAL
BUY
DAIWA
Low
-1.7%
12/10
03:10 pm
Maintains
Overweight
Overweight
Wells Fargo
Low
-0.3%
12/23
12:53 pm
lly
Low
Form 144 ELI LILLY & Co Filed by: LILLY ENDOWMENT INC
12/16
04:47 pm
lly
Low
Form 4 ELI LILLY & Co For: Dec 15 Filed by: Sulzberger Gabrielle
12/16
04:45 pm
lly
Low
Form 4 ELI LILLY & Co For: Dec 15 Filed by: LUCIANO JUAN R
12/16
04:43 pm
lly
Low
Form 4 ELI LILLY & Co For: Dec 15 Filed by: Hedley Mary Lynne
12/16
04:42 pm
lly
Low
Form 4 ELI LILLY & Co For: Dec 15 Filed by: Fyrwald J Erik
Show more
Top News Gainers
3/12 Eli Lilly, AbCellera Biologics to co-develop coronavirus therapies [Reuters] 14.2%
3/2 U.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis 5.8%
4/13 Despite Qualms, Arthritis Drug to Be Tested in Coronavirus Study [The New York Times] 4.6%
4/2 Eli Lilly And Co (NYSE: LLY) had its price target lowered by analysts at Morgan Stanley from $150.00 to $148.00. They now have an "overweight" rating on the stock. 4.2%
3/23 FDA enacts abbreviated approval pathway for insulin biosimilars [Seeking Alpha] 3.2%
4/16 Lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen® now available 3.2%
10/28 Insider Buying: The Eli Lilly and Company (NYSE:LLY) Chairman Just Bought US$500k Worth Of Shares [Yahoo! Finance News] 2.7%
2/4 Form 4 ELI LILLY & Co For: Feb 01 Filed by: Zulueta Alfonso G 2.7%
12/18 Lilly Announces the Launch of TRIUMPH, the First, Long-Term, Real-World Evidence Study of Emgality® (galcanezumab-gnlm) 2.7%
3/23 Lilly Provides Update on Clinical Trial Activities During COVID-19 Pandemic 2.6%
Top News Decliners
3/11 Eli Lilly to Participate in Program to Make Insulin Cheaper for Seniors [The Motley Fool] -10.0%
3/18 Hap Sneddon's Top Picks: March 18, 2020 [Business News Network (BNN) Energy & Resources (Canada)] -7.6%
3/20 Form DEFA14A ELI LILLY & Co -5.8%
7/11 New England Journal of Medicine Publishes Positive Phase 3 Data for Emgality® (galcanezumab-gnlm) in Episodic Cluster Headache -5.3%
6/9 Lilly's ultra rapid lispro provided similar A1C reductions compared to Humalog® (insulin lispro), with superior post-meal blood glucose reductions -4.0%
8/14 Lilly Launches Open Innovation Challenge to Help Transform Inflammatory Bowel Disease (IBD) Care through Digital Health -4.0%
4/28 Form 8-K ELI LILLY & Co For: Apr 24 -3.5%
2/27 Local Organization NOVA ScriptsCentral Benefits BIG with Eli Lilly release of Bulk Donation Insulin Pens -3.4%
2/21 Trulicity® (dulaglutide) is the first and only type 2 diabetes medicine approved to reduce cardiovascular events in adults with and without established cardiovascular disease -3.4%
8/5 Lilly Announces Positive Results for Emgality® (galcanezumab-gnlm) from the CONQUER Study in Patients who Failed Previous Migraine Preventive Treatments -3.4%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3